Arrivent Biopharma Inc (AVBP)

06:26 AM

Candlestick signals on ArriVent BioPharma Inc. stock todayForecast Cut & Technical Pattern Recognition Alerts - Newser

06:26 AM

03:16 AM

How to interpret RSI for ArriVent BioPharma Inc. stockMarket Activity Summary & Free High Return Stock Watch Alerts - Newser

03:16 AM

01:58 AM

What machine learning models say about ArriVent BioPharma Inc.Market Performance Summary & Fast Entry Momentum Alerts - Newser

01:58 AM

01:57 AM

Does ArriVent BioPharma Inc. fit your quant trading modelWeekly Market Outlook & Safe Entry Trade Signal Reports - Newser

01:57 AM

01:39 AM

ArriVent BioPharma Posts Q2 Loss as Cancer Drug Pipeline Advances Toward Key Milestones - MSN

01:39 AM

12:42 PM

Will ArriVent BioPharma Inc. outperform the marketWeekly Profit Report & Verified Swing Trading Watchlist - Newser

12:42 PM

Aug 15, 2025

News impact scoring models applied to ArriVent BioPharma Inc.Weekly Profit Analysis & Long-Term Safe Investment Plans - Newser

Aug 15, 2025

Aug 15, 2025

Will ArriVent BioPharma Inc. price bounce be sustainableMarket Activity Report & Long-Term Safe Investment Plans - Newser

Aug 15, 2025

Aug 15, 2025

Comparing ArriVent BioPharma Inc. in custom built stock radars2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser

Aug 15, 2025

Aug 15, 2025

Advanced analytics toolkit walkthrough for ArriVent BioPharma Inc.Product Launch & Safe Entry Trade Signal Reports - Newser

Aug 15, 2025

Aug 15, 2025

Trend analysis for ArriVent BioPharma Inc. this weekMarket Activity Report & Daily Profit Focused Screening - Newser

Aug 15, 2025

Aug 15, 2025

ArriVent BioPharma Inc. recovery potential after sell offEarnings Recap Summary & Risk Managed Investment Entry Signals - Newser

Aug 15, 2025

Aug 15, 2025

Can trapped investors hope for a rebound in ArriVent BioPharma Inc.Gap Down & Weekly Setup with High ROI Potential - Newser

Aug 15, 2025

Aug 15, 2025

ArriVent BioPharma Inc. Stock Lags Behind Sector Benchmarks2025 Price Momentum & Fast Moving Trade Plans - beatles.ru

Aug 15, 2025

Aug 14, 2025

ArriVent BioPharma Inc. Recovery Hinges on Volume Breakout2025 Biggest Moves & Weekly High Return Forecasts - metal.it

Aug 14, 2025

Aug 14, 2025

Omega Advisors' Q2 Holdings: New Buys, Exits, and Stakes Increased - AInvest

Aug 14, 2025

Aug 14, 2025

ArriVent BioPharma Inc. Price Targets Raised After ReboundMarket Trend Review & Real-Time Sentiment Analysis - mustnews.co.kr

Aug 14, 2025

Aug 14, 2025

ArriVent Biopharma price target lowered to $33 from $40 at Citi - MSN

Aug 14, 2025

Aug 14, 2025

Is ArriVent BioPharma Inc. trending in predictive chart models2025 Price Targets & Community Consensus Picks - Newser

Aug 14, 2025

Aug 14, 2025

ArriVent BioPharma Advances Cancer Therapeutics Pipeline - MSN

Aug 14, 2025

Aug 13, 2025

Mineralys: HC Wainwright Raises PT to $42, Maintains Buy Rating - AInvest

Aug 13, 2025

Aug 13, 2025

Guggenheim Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $45 - 富途牛牛

Aug 13, 2025

Aug 13, 2025

ArriVent BioPharma Inc. stock retracement – recovery analysisM&A Rumor & Real-Time Volume Trigger Notifications - Newser

Aug 13, 2025

Aug 12, 2025

ArriVent Biopharma price target raised to $42 from $40 at H.C. Wainwright - TipRanks

Aug 12, 2025

Aug 12, 2025

A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $33 to $45 - 富途牛牛

Aug 12, 2025

Aug 12, 2025

H.C. Wainwright raises ArriVent BioPharma stock price target to $42 on NSCLC drug potential - Investing.com Canada

Aug 12, 2025

Aug 12, 2025

ArriVent BioPharma Inc. stock trend outlook and recovery pathFree Short Term High Yield Stock Tips - Newser

Aug 12, 2025

Aug 12, 2025

What makes ArriVent BioPharma Inc. stock price move sharplyFree Real Time Alerts Based on AI Prediction - Newser

Aug 12, 2025

Aug 12, 2025

ArriVent Biopharma sees cash runway into mid-2027 - TipRanks

Aug 12, 2025

Aug 11, 2025

Why ArriVent BioPharma Inc. stock attracts strong analyst attentionFree Low Capital High Return Stock Plans - Newser

Aug 11, 2025

Aug 11, 2025

ArriVent Biopharma reports Q2 EPS (90c), consensus (71c) - TipRanks

Aug 11, 2025

Aug 11, 2025

Does ArriVent BioPharma Inc. qualify in momentum factor screeningSector Rotation Strategy for Smart Traders - Newser

Aug 11, 2025

Aug 11, 2025

Understanding ArriVent BioPharma Inc.’s price movementFree Breakout Entry Signal Confirmation Tool - Newser

Aug 11, 2025

Aug 11, 2025

ArriVent BioPharma Reports Q2 GAAP EPS of -$0.90, Misses Expectations - AInvest

Aug 11, 2025

Aug 11, 2025

ArriVent BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 11, 2025

Aug 11, 2025

ArriVent Posts Wider Loss in Fiscal Q2 - The Motley Fool

Aug 11, 2025

Aug 11, 2025

ArriVent Posts Wider Loss in Fiscal Q2 - The Globe and Mail

Aug 11, 2025

Aug 11, 2025

ArriVent BioPharma, Inc. SEC 10-Q Report - TradingView

Aug 11, 2025

Aug 11, 2025

ArriVent's Lung Cancer Drug Shows Promise in Phase 1b Trial, Reports $335M Cash Position - Stock Titan

Aug 11, 2025

Aug 11, 2025

Custom strategy builders for tracking ArriVent BioPharma Inc.Free Triple Return Setup with Risk Control - Newser

Aug 11, 2025

Aug 11, 2025

ArriVent BioPharma (AVBP) Projected to Post Quarterly Earnings on Wednesday - Defense World

Aug 11, 2025

Aug 11, 2025

Predicting ArriVent BioPharma Inc. trend using moving averagesFree Consistent Profit Pattern Recognition Tools - Newser

Aug 11, 2025

Aug 10, 2025

How hedge fund analytics apply to ArriVent BioPharma Inc. stockEntry Confirmation Using Short-Term Forecasting - Newser

Aug 10, 2025